Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Stage-specific regulation of oligodendrocyte development by Hedgehog signaling in the spinal cord.

Xiaofeng Xu | Qian Yu | Minxi Fang | Min Yi | Aifen Yang | Binghua Xie | Junlin Yang | Zunyi Zhang | Zhongmin Dai | Mengsheng Qiu
Glia | 2020

Elucidation of signaling pathways that control oligodendrocyte (OL) development is a prerequisite for developing novel strategies for myelin repair in neurological diseases. Despite the extensive work outlining the importance of Hedgehog (Hh) signaling in the commitment and generation of OL progenitor cells (OPCs), there are conflicting reports on the role of Hh signaling in regulating OL differentiation and maturation. In the present study, we systematically investigated OPC specification and differentiation in genetically modified mouse models of Smoothened (Smo), an essential component of the Hh signaling pathway in vertebrates. Through conditional gain-of-function strategy, we demonstrated that hyperactivation of Smo in neural progenitors induced transient ectopic OPC generation and precocious OL differentiation accompanied by the co-induction of Olig2 and Nkx2.2. After the commitment of OL lineage, Smo activity is not required for OL differentiation, and sustained expression of Smo in OPCs stimulated cell proliferation but inhibited terminal differentiation. These findings have uncovered the stage-specific regulation of OL development by Smo-mediated Hh signaling, providing novel insights into the molecular regulation of OL differentiation and myelin repair.

Pubmed ID: 31605511

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Caspase 3, active (cleaved) form (antibody)

RRID:AB_91556

This polyclonal targets Caspase 3 active (cleaved) form

View all literature mentions

Ki67 antibody - Proliferation Marker (antibody)

RRID:AB_443209

This polyclonal targets Ki67 antibody - Proliferation Marker

View all literature mentions

ANTI-OLIG-2 (antibody)

RRID:AB_570666

This polyclonal targets Oligodendrocute transcription factor 2

View all literature mentions

B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (organism)

RRID:IMSR_JAX:007909

Mus musculus with name B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J from IMSR.

View all literature mentions

STOCK Gt(ROSA)26Sortm1(Smo/EYFP)Amc/J (organism)

RRID:IMSR_JAX:005130

Mus musculus with name STOCK Gt(ROSA)26Sortm1(Smo/EYFP)Amc/J from IMSR.

View all literature mentions

STOCK Smotm2Amc/J (organism)

RRID:IMSR_JAX:004526

Mus musculus with name STOCK Smotm2Amc/J from IMSR.

View all literature mentions

B6.Cg-Tg(Nes-cre)1Kln/J (organism)

RRID:IMSR_JAX:003771

Mus musculus with name B6.Cg-Tg(Nes-cre)1Kln/J from IMSR.

View all literature mentions

B6N.Cg-Tg(Pdgfra-cre/ERT)467Dbe/J (organism)

RRID:IMSR_JAX:018280

Mus musculus with name B6N.Cg-Tg(Pdgfra-cre/ERT)467Dbe/J from IMSR.

View all literature mentions